BLACK DIAMOND THERAPEUTICS, INC. Increase (Decrease) in Accounts Payable, Trade
BLACK DIAMOND THERAPEUTICS, INC. (BDTX) reported Increase (Decrease) in Accounts Payable, Trade of $825.00 thousand for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-05.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInAccountsPayableTrade · last filed 2026-08-05
- BLACK DIAMOND THERAPEUTICS, INC. increase (decrease) in accounts payable, trade for the quarter ending 2026-06-30 was -$1.56M.
- BLACK DIAMOND THERAPEUTICS, INC. increase (decrease) in accounts payable, trade for the quarter ending 2026-03-31 was $2.39M.
- BLACK DIAMOND THERAPEUTICS, INC. increase (decrease) in accounts payable, trade for the quarter ending 2025-12-31 was -$396.00K, a 119.45% decline year-over-year.
- BLACK DIAMOND THERAPEUTICS, INC. increase (decrease) in accounts payable, trade for the quarter ending 2025-09-30 was $204.00K, a 83.11% decline year-over-year.
- BLACK DIAMOND THERAPEUTICS, INC. increase (decrease) in accounts payable, trade for fiscal 2025 was -$3.43M, a 303.68% decline from fiscal 2024.
- BLACK DIAMOND THERAPEUTICS, INC. increase (decrease) in accounts payable, trade for fiscal 2024 was $1.68M, a 181.91% increase from fiscal 2023.
- BLACK DIAMOND THERAPEUTICS, INC. increase (decrease) in accounts payable, trade for fiscal 2023 was $597.00K.
- BLACK DIAMOND THERAPEUTICS, INC. increase (decrease) in accounts payable, trade for fiscal 2022 was -$2.23M, a 242.13% decline from fiscal 2021.
| Period end | Increase (Decrease) in Accounts Payable, Trade 3 month | Increase (Decrease) in Accounts Payable, Trade 6 month | Increase (Decrease) in Accounts Payable, Trade 9 month | Increase (Decrease) in Accounts Payable, Trade 12 month |
|---|---|---|---|---|
| 2026-06-30 | -$1.56M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-05 | $825.00K 10-Q · filed 2026-08-05 | $429.00K derived: sum of 3 quarters · filed 2026-08-05 | $633.00K derived: sum of 4 quarters · filed 2026-08-05 |
| 2026-03-31 | $2.39M 10-Q · filed 2026-05-07 | $1.99M derived: sum of 2 quarters · filed 2026-05-07 | $2.20M derived: sum of 3 quarters · filed 2026-05-07 | $341.00K derived: sum of 4 quarters · filed 2026-08-05 |
| 2025-12-31 | -$396.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-16 | -$192.00K derived: sum of 2 quarters · filed 2026-03-16 | -$2.05M derived: sum of 3 quarters · filed 2026-08-05 | -$3.43M 10-K · filed 2026-03-16 |
| 2025-09-30 | $204.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-06 | -$1.65M derived: sum of 2 quarters · filed 2026-08-05 | -$3.03M 10-Q · filed 2025-11-06 | -$996.00K derived: sum of 4 quarters · filed 2026-08-05 |
| 2025-06-30 | -$1.86M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-05 | -$3.24M 10-Q · filed 2026-08-05 | -$1.20M derived: sum of 3 quarters · filed 2026-08-05 | $8.00K derived: sum of 4 quarters · filed 2026-08-05 |
| 2025-03-31 | -$1.38M 10-Q · filed 2026-05-07 | $657.00K derived: sum of 2 quarters · filed 2026-05-07 | $1.86M derived: sum of 3 quarters · filed 2026-05-07 | $1.43M derived: sum of 4 quarters · filed 2026-05-07 |
| 2024-12-31 | $2.04M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-16 | $3.24M derived: sum of 2 quarters · filed 2026-03-16 | $2.81M derived: sum of 3 quarters · filed 2026-03-16 | $1.68M 10-K · filed 2026-03-16 |
| 2024-09-30 | $1.21M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-06 | $775.00K derived: sum of 2 quarters · filed 2025-11-06 | -$353.00K 10-Q · filed 2025-11-06 | $1.28M derived: sum of 4 quarters · filed 2025-11-06 |
| 2024-06-30 | -$433.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-07 | -$1.56M 10-Q · filed 2025-08-07 | $69.00K derived: sum of 3 quarters · filed 2025-08-07 | -$1.79M derived: sum of 4 quarters · filed 2025-08-07 |
| 2024-03-31 | -$1.13M 10-Q · filed 2025-05-12 | $502.00K derived: sum of 2 quarters · filed 2025-05-12 | -$1.36M derived: sum of 3 quarters · filed 2025-05-12 | -$1.70M derived: sum of 4 quarters · filed 2025-05-12 |
| 2023-12-31 | $1.63M derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-06 | -$229.00K derived: sum of 2 quarters · filed 2025-03-06 | -$572.00K derived: sum of 3 quarters · filed 2025-03-06 | $597.00K 10-K · filed 2025-03-06 |
| 2023-09-30 | -$1.86M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-05 | -$2.20M derived: sum of 2 quarters · filed 2024-11-05 | -$1.03M 10-Q · filed 2024-11-05 | -$4.92M derived: sum of 4 quarters · filed 2024-11-05 |
| 2023-06-30 | -$343.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-06 | $826.00K 10-Q · filed 2024-08-06 | -$3.06M derived: sum of 3 quarters · filed 2024-08-06 | $481.00K derived: sum of 4 quarters · filed 2024-08-06 |
| 2023-03-31 | $1.17M 10-Q · filed 2024-05-09 | -$2.71M derived: sum of 2 quarters · filed 2024-05-09 | $824.00K derived: sum of 3 quarters · filed 2024-05-09 | $1.16M derived: sum of 4 quarters · filed 2024-05-09 |
| 2022-12-31 | -$3.88M derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-12 | -$345.00K derived: sum of 2 quarters · filed 2024-03-12 | -$6.00K derived: sum of 3 quarters · filed 2024-03-12 | -$2.23M 10-K · filed 2024-03-12 |
| 2022-09-30 | $3.54M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-06 | $3.88M derived: sum of 2 quarters · filed 2023-11-06 | $1.65M 10-Q · filed 2023-11-06 | $959.00K derived: sum of 4 quarters · filed 2023-11-06 |
| 2022-06-30 | $339.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-11 | -$1.89M 10-Q · filed 2023-08-11 | -$2.58M derived: sum of 3 quarters · filed 2023-08-11 | -$1.95M derived: sum of 4 quarters · filed 2023-08-11 |
| 2022-03-31 | -$2.22M 10-Q · filed 2023-05-09 | -$2.92M derived: sum of 2 quarters · filed 2023-05-09 | -$2.29M derived: sum of 3 quarters · filed 2023-05-09 | -$2.65M derived: sum of 4 quarters · filed 2023-05-09 |
| 2021-12-31 | -$694.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-09 | -$66.00K derived: sum of 2 quarters · filed 2023-03-09 | -$422.00K derived: sum of 3 quarters · filed 2023-03-09 | $1.57M 10-K · filed 2023-03-09 |
| 2021-09-30 | $628.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-08 | $272.00K derived: sum of 2 quarters · filed 2022-11-08 | $2.26M 10-Q · filed 2022-11-08 | $1.80M derived: sum of 4 quarters · filed 2022-11-08 |
| 2021-06-30 | -$356.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-09 | $1.64M 10-Q · filed 2022-08-09 | $1.18M derived: sum of 3 quarters · filed 2022-08-09 | $4.06M derived: sum of 4 quarters · filed 2022-08-09 |
| 2021-03-31 | $1.99M 10-Q · filed 2022-05-11 | $1.53M derived: sum of 2 quarters · filed 2022-05-11 | $4.42M derived: sum of 3 quarters · filed 2022-05-11 | $666.00K derived: sum of 4 quarters · filed 2022-05-11 |
| 2020-12-31 | -$459.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-17 | $2.43M derived: sum of 2 quarters · filed 2022-03-17 | -$1.32M derived: sum of 3 quarters · filed 2022-03-17 | $1.07M 10-K · filed 2022-03-17 |
| 2020-09-30 | $2.89M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-08 | -$866.00K derived: sum of 2 quarters · filed 2021-11-08 | $1.53M 10-Q · filed 2021-11-08 | $2.49M derived: sum of 4 quarters · filed 2021-11-08 |
| 2020-06-30 | -$3.75M derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-12 | -$1.36M 10-Q · filed 2021-08-12 | -$401.00K derived: sum of 3 quarters · filed 2021-08-12 | -$175.00K derived: sum of 4 quarters · filed 2021-08-12 |
| 2020-03-31 | $2.39M 10-Q · filed 2021-05-07 | $3.35M derived: sum of 2 quarters · filed 2021-05-07 | $3.58M derived: sum of 3 quarters · filed 2021-05-07 | $3.90M derived: sum of 4 quarters · filed 2021-05-07 |
| 2019-12-31 | $958.00K derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-25 | $1.18M derived: sum of 2 quarters · filed 2021-03-25 | $1.51M derived: sum of 3 quarters · filed 2021-03-25 | $1.45M 10-K · filed 2021-03-25 |
| 2019-09-30 | $226.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-10 | $550.00K derived: sum of 2 quarters · filed 2020-11-10 | $496.00K 10-Q · filed 2020-11-10 | |
| 2019-06-30 | $324.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-11 | $270.00K 10-Q · filed 2020-08-11 | ||
| 2019-03-31 | -$54.00K 10-Q · filed 2020-05-12 | |||
| 2018-12-31 | $264.00K 10-K · filed 2020-03-24 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Cardiff Oncology, Inc. (CRDF) | United States | $0.101B | -2.22 |
| LENZ Therapeutics, Inc. (LENZ) | United States | $0.117B | -1.41 |
| COGNITION THERAPEUTICS INC (CGTX) | United States | $0.090B | -6.52 |
| enGene Therapeutics Inc. (ENGN) | $0.129B | -0.92 | |
| Pelthos Therapeutics Inc. (PTHS) | United States | $0.086B | -1.20 |
| Atara Biotherapeutics, Inc. (ATRA) | United States | $0.086B | -6.48 |
| Neumora Therapeutics, Inc. (NMRA) | United States | $0.132B | -1.48 |
| Armata Pharmaceuticals, Inc. (ARMP) | United States | $0.132B | |
| Caribou Biosciences, Inc. (CRBU) | United States | $0.134B | -1.79 |
| Vaxart, Inc. (VXRT) | United States | $0.080B | 3.84 |